Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Clinical and Vaccine Immunology : CVI|February 12, 2016
Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and EnteritidisOmar Rossi, Mariaelena Caboni, Aurel Negrea, et al.
Vaccine|January 30, 2025
Vaccines and AMR: An analysis of the funding landscape for human bacterial vaccines in low-and middle-income countriesCatherine Fleck-Vidal, Anna Doubell, Christiane Gerke, et al.
The Journal of Biological Chemistry|July 16, 2014
Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutantsOmar Rossi, Isabella Pesce, Carlo Giannelli, et al.
Plos One|August 7, 2015
Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHBChristiane Gerke, Anna Maria Colucci, Carlo Giannelli, et al.
Plos One|June 16, 2012
High yield production process for Shigella outer membrane particlesFrancesco Berlanda Scorza, Anna Maria Colucci, Luana Maggiore, et al.
Plos Pathogens|March 21, 2015
An O antigen capsule modulates bacterial pathogenesis in Shigella sonneiMariaelena Caboni, Thierry Pédron, Omar Rossi, et al.
Frontiers in Immunology|July 12, 2019
A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic MiceClaude Roth, Tineke Cantaert, Chloé Colas, et al.
Plos Pathogens|December 4, 2009
The Salmonella SPI2 effector SseI mediates long-term systemic infection by modulating host cell migrationLaura M McLaughlin, Gregory R Govoni, Christiane Gerke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 29, 2022
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosaBenjamin Vesin, Jodie Lopez, Amandine Noirat, et al.
Ebiomedicine|July 25, 2017
Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in EuropeOdile Launay, David J M Lewis, Alessandra Anemona, et al.
Pageof 3